Seroatlas · Human Serome Atlas

PF4

Platelet factor 4

Also known as: CXCL4, PLF4_HUMAN, SCYB4

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P02776
Gene
PF4
Ensembl
ENSG00000163737
Chromosome
4
Canonical length
101 aa
Protein class
Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins
Secretome location
Secreted to blood
Quaternary structure
Homotetramer

OverviewNCBI Gene

This gene encodes a member of the CXC chemokine family. This chemokine is released from the alpha granules of activated platelets in the form of a homotetramer which has high affinity for heparin and is involved in platelet aggregation. This protein is chemotactic for numerous other cell type and also functions as an inhibitor of hematopoiesis, angiogenesis and T-cell function. The protein also exhibits antimicrobial activity against Plasmodium falciparum. [provided by RefSeq, Oct 2014]

Canonical amino-acid sequenceUniProt

101 residues, UniProt reviewed canonical sequence.

>P02776|PF4
     1  MSSAAGFCAS RPGLLFLGLL LLPLVVAFAS AEAEEDGDLQ CLCVKTTSQV RPRHITSLEV
    61  IKAGPHCPTA QLIATLKNGR KICLDLQAPL YKKIIKKLLE S

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against PF4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.49
Highest tissue expression
28 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 28 nTPM
  • spleen: 9.8 nTPM
  • lung: 3.2 nTPM
  • placenta: 1.6 nTPM
  • tongue: 1.4 nTPM
  • gallbladder: 0.5 nTPM

Single-cell type

  • platelets: 1,437 nCPM
  • megakaryocytes: 940 nCPM
  • megakaryocyte progenitors: 48 nCPM
  • erythrocytes: 1.9 nCPM
  • neutrophil progenitors: 1 nCPM
  • pdcs: 0.7 nCPM

Immune cell

  • total PBMC: 3.1 nTPM
  • neutrophil: 2 nTPM
  • basophil: 0.4 nTPM
  • plasmacytoid DC: 0.2 nTPM
  • T-reg: 0.2 nTPM
  • classical monocyte: 0 nTPM

Brain region

  • cerebral cortex: 1.9 nTPM
  • choroid plexus: 0.6 nTPM
  • white matter: 0.4 nTPM
  • basal ganglia: 0.3 nTPM
  • medulla oblongata: 0.3 nTPM
  • pons: 0.3 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about PF4.

Disease | AutoantibodyPubMed

Conditions in which antibodies against PF4 are reported. Each links to that disease's full target list.

Showing 5 of 6 — disease pages carrying at least 10 antigens.

ReferencesPubMed · IEDB

Publications for PF4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: AutoantibodyPubMed

60 publications

Show 20 more of 60 total

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.73
gnomAD pLI
0.04
gnomAD missense Z
0.26
DepMap mean gene effect
-0.24
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of PF4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads PF4 as an antibody target. Whether an autoantibody or antibody against PF4 could matter depends on whether native PF4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

PF4 is annotated as secreted, so native PF4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label PF4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/PF4. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...